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Strengths and limitations of this study
 ► It involved representatives of various stakeholders of 
community pharmacy including the public.
 ► The use of the HumanFactors Framework to cate-
gorise and prioritise medication safety problems 
equates to a universal language that can be under-
stood in different healthcare disciplines and beyond 
the healthcare field.
 ► Online surveys may be subject to selection bias.
 ► A high percentage of pharmacy users chose ‘I do not 
know’ in Round 1 and 2.
 ► There was unequal representation from the three 
stakeholder groups in each of the three rounds.
AbStrACt
Aim To achieve multi- stakeholder consensus and 
prioritisation of medication safety problems in community 
pharmacies in Saudi Arabia.
Design and intervention A theoretically- underpinned, 
three- round Delphi study.
Setting Saudi Arabia.
Participants Patients and public (pharmacy users), 
pharmacy- related professionals (policymakers, academics, 
medication safety officers and pharmacy owners) and 
community pharmacists.
Methods Round 1 comprised 84 statements derived from 
a qualitative study. The items were grouped according 
to the Human Factors Framework (HFF). Rounds 1 and 2 
aimed to achieve consensus, 6- point Likert response scale 
(agreement/disagreement) was used. Round 3 aimed to 
prioritise the items for which consensus was achieved 
in Rounds 1 and 2 indicated on a 5- point scale (very 
important to unimportant). Consensus was predefined as 
any item that achieved ≥70%.
results The number of respondents in Rounds 1, 2 and 
3 was 161, 120 and 112, respectively. In all three rounds, 
the majority of respondents were pharmacy users (Round 
1 77% (n=124), Round 2 74% (n=89), Round 3 72% 
(n=81)). Consensus was achieved with 28/84 items. The 
top five medication safety priorities were: lack of pharmacy 
facilities such as counselling area, lack of communication 
between pharmacists and physicians, lack of patient 
databases, lack of post- registration pharmacist education 
and pharmacists’ long working hours. The professional 
and pharmacy user groups achieved consensus on similar 
items through different categories of the HFFs. Community 
pharmacists had the highest percentage of consensus 
among the three groups for factors related to work, such 
as high workload and low salaries.
Conclusion This multi- stakeholder study used the HFF 
to identify and prioritise the main medication safety 
challenges facing community pharmacy in Saudi Arabia. 
It indicates the need for changes to practice and policy 
and further research to address these priorities and 
promote medication safety at an individual, pharmacy and 
population level.
IntroDuCtIon
Community pharmacy is a complex system 
involving many interacting factors that 
influence medication safety.1–4 Medication 
safety is defined as ‘freedom from accidental 
injury during the course of medication use; 
activities to avoid, prevent or correct adverse 
drug events, which may result from the use of 
medications’.5
In Saudi Arabia, community pharmacies 
continue to be product- oriented, despite the 
introduction of a patient- oriented model in 
the early 1970s.6 In 2018 the Saudi Ministry 
of Health (MOH) started to enforce regula-
tions about the supply of antibiotics without 
prescription with financial penalties of up to 
£21 000, loss of pharmacy license and possible 
imprisonment for up to 6 months for pharma-
cists who violated this legislation.7 In 2019 the 
MOH launched an initiative to upgrade health 
services called ‘Wasfati’. It allows the benefi-
ciaries of free governmental health services 
(primary or secondary) to obtain medicines 
from the community pharmacy (private) closest 
to them at the right time and free of charge, 
instead of only from the outpatient pharmacy 
in the governmental hospitals as happened 
previously.8 While this initiative has created 
an opportunity to develop the community 
pharmacist role, it also generates medication 
safety concerns.1 The main medication safety 
Protected by copyright.
 o
n
 N
ovem
ber 21, 2019 at University of Strathclyde Library.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032419 on 5 November 2019. Downloaded from 
2 Al Juffali LA, et al. BMJ Open 2019;9:e032419. doi:10.1136/bmjopen-2019-032419
Open access 
Table 1 Participants' responses by group across all rounds
Questionnaires
Round 1 Round 2 Round 3
No. sent
Participants
% (n) No. sent
Participants
% (n) No. sent
Participants
% (n)
Pharmacy users 284 43.6 (124) 119 74.7 (89) 119 68.0 (81)
Professionals 37 32.4 (12) 12 91.6 (11) 12 83.3 (10)
Community pharmacists 38 65.7 (25) 23 86 (20) 23 91.3 (21)
Total 359 44.8 (161) 154 79.2 (120) 154 72.7 (112)
problems identified in Saudi community pharmacy setting 
include commercial pressures, failure to enforce regula-
tions, the fragmented healthcare system, self- medication 
with prescription- only medicines, inappropriate medica-
tion storage and excessive pharmacist workload.1
In order to develop strategies and interventions to 
address these diverse challenges, there was a need to priori-
tise which medication safety problems should be addressed. 
The Delphi method serves as a virtual meeting with a diverse 
group of experts to communicate and provide opinions on 
a practice- related matter.9
Various theories and frameworks, including the Human 
Factors Framework (HFF), have been identified to explore 
factors influencing patient safety10–15 and aid under-
standing of people’s strengths and weaknesses, allowing 
design of better systems.16 The HFF incorporates a number 
of factors associated with the occurrence of safety problems 
such as those related to patients, individuals, teamwork, 
the work environment, the task, as well as managerial, 
organisational and external factors. Evidence shows that 
the HFF is efficient in aiding the identification of factors 
and the design of systems to promote patient safety.16 The 
HFF incorporates a universal language that can be under-
stood by all patient safety stakeholders. It enables research 
findings to be communicated to various disciplines and 
ensures an understanding of medication safety challenges 
in the community pharmacy context. Furthermore, this 
means that identified challenges to medication safety can 
be compared with similar difficulties experienced by other 
disciplines and mutual experiences can then be shared.
The aim of this study, therefore, was to adopt a 
theoretically- underpinned approach to derive consensus 
and prioritise medication safety problems in community 
pharmacy in Saudi Arabia.
MethoDS
Study design
A three- round Delphi study was conducted with three stake-
holder groups (pharmacy users, ‘professionals’ and commu-
nity pharmacists). A web- based Delphi study (e- Delphi) and 
a paper questionnaire were used concurrently depending 
on participant preference.
Statement development
The medication safety items included in Round 1 were 
derived from the results of an earlier study.1 A total of 119 
statements was generated and categorised using the HFF 
(categories: external, organisational and management, 
work, physician, pharmacist, communication and informa-
tion exchange, task, medication factors, patient behaviour 
and patient characteristics).
The Delphi items and response options were piloted with 
15 individuals (five people from each of three groups; phar-
macy users, professionals and community pharmacists). 
Their feedback indicated that the number of items was 
excessive. In addition, pharmacy users suggested adding an 
option ‘I do not know’ to the 5- point Likert scale. As a result 
of piloting, the total number of items was reduced to 84 
statements (online supplementary table 1) (table 1).
Determining consensus
A 6- point Likert scale was used to rate the level of agree-
ment/disagreement with each statement: strongly disagree, 
disagree, agree, strongly agree and ‘I do not know’. 
Consensus was predefined as any item that reached >70% 
agreement (ie, 4 or 5 on the Likert scale) or disagreement 
(ie, 1 or 2 on the Likert scale). The cut point of 70% was 
based on published recommendations.17–20 A systematic 
review that investigated how consensus is operationalised 
in Delphi studies found that the definitions of consensus 
vary widely with 75% being the median threshold to define 
consensus and the range is 50% to 97%.17
Participant identification and recruitment
The aim was to recruit 25 participants in each group; the 
recommended average Delphi study panel size is 10 to 30 
members.9 21 Participants were identified through a number 
of sources. Saudi adult pharmacy users were recruited using 
a range of methods. The social network Twitter, was used to 
recruit Saudis from a wide geographical area. A URL link 
to the study was tweeted to invite Saudis aged 18 years and 
over to participate. Non- Saudi nationals and individuals 
under 18 years of age were excluded. To ensure maximum 
variation in age, education level and other demographics, a 
snowballing recruitment technique was used.22 Individuals 
who agreed to participate were asked to invite other indi-
viduals of a different gender, age or educational level either 
personally or by re- tweeting the study link.
The ’professional‘ group in this study were those working 
in organisations that regulate and monitor community 
pharmacies, pharmacists and medicine supply in Saudi 
Arabia (ie, policymakers, academics, medication safety offi-
cers and pharmacy owners).
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The professionals were recruited purposively through 
professional and personal networks.
Community pharmacists working in Riyadh, for a 
minimum of 1 year were eligible to participate. It is worth 
noting that all community pharmacists in Saudi Arabia are 
male and the majority are non- Saudi. In Saudi there are 20 
governmental colleges of pharmacy and the majority of the 
Saudi graduate works in hospitals. Thus, 99% of commu-
nity pharmacists are non–Saudi, with Egyptians being the 
predominant nationals.23–31
They were selected purposively for the study to achieve 
a mix of pharmacists from five areas in Riyadh (north, 
west, east, south and the centre) and different types of 
pharmacies, including independent, clinic- affiliated and 
chain pharmacies.
Pharmacy users, professionals, community pharmacists 
participated in a previous focus group study were also 
invited to participate.1
All participants received the same invitation pack that 
included an invitation letter, a study information sheet 
and consent form. The invitations were followed by two 
reminders sent by email, WhatsApp or Twitter. The ques-
tionnaires were anonymised.
Patient and public involvement
Members of the public participated in this research, as they 
comprised one of the stakeholder groups. Members of the 
public were not invited to comment on the study design, 
were not consulted to develop patient relevant outcomes or 
interpret the results and were not invited to contribute to the 
writing or editing of this manuscript for readability or accuracy.
round 1
Rounds 1 and 2 aimed to achieve consensus on medication 
safety problems. Round 1 of the questionnaire contained 
two parts. Part 1 listed the medication safety problems 
statements. A space at the end of the list was provided to 
encourage participants to note any other problems related 
to medication safety and for general comments. Part 2 
captured demographic data including (for professional and 
community pharmacists) years of experience, educational 
background, professional role and country of residence.
round 2
Round 2 also comprised two parts. Part 1 summarised all 
statements for which consensus was achieved in Round 1. 
These items were presented as feedback to participants and 
no further responses were required to these items. Part 2 
contained all Round 1 items that did not achieve consensus 
(not included in Part 1 list). No changes were made to the 
items apart from adding the feedback from Round 1 as a 
percentage alongside each statement.
round 3
The purpose of Round 3 was to prioritise the medica-
tion safety problems for which consensus was achieved in 
Rounds 1 or 2. The stem of each consensus statement was 
modified: instead of asking participants about agreement, 
participants were asked to rate the importance of each item 
using a 5- point Likert scale, from 1 to 5: (1=very important 
to 5=unimportant). Participants were also asked under 
each category, ‘What are the most important medication 
safety problems in this category?’.
A pilot study was conducted for Round 3, the aim of 
which was to confirm whether participants understood the 
new stem question. Participants acknowledged the ease 
of the questionnaire. The average completion time for 
the Round 3 questionnaire was 20 min based on the pilot 
questionnaire.
Questionnaire administration
Each round was conducted over a maximum of 8 weeks: 
3 weeks for response acquisition, and two reminders, as 
required, sent at 2 week intervals (figure 1). A closing date 
for each round was stated. Three weeks were set aside for 
analysing data and preparing for the subsequent round. The 
questionnaires were sent to all participants who completed 
Round 1, together with corresponding instructions for 
each round. After completing the questionnaire, partic-
ipants were thanked and provided information about the 
next round. Participants were also asked about their pref-
erence for receiving the next round questionnaire, either 
by email or social media (WhatsApp or Twitter), which they 
could do confidentially and securely. To match the answers 
from participants across consecutive rounds, participants 
were asked to provide their mobile phone numbers as their 
unique identification number in all rounds. The question-
naire was developed in SurveyMonkey (SurveyMonkey Inc, 
San Mateo, California, USA) and its functioning pilot tested 
by the research team.
Data analysis
Data generated from the online version were extracted to 
Microsoft Excel for descriptive analysis (frequencies and 
percentages) to identify whether or not consensus had 
been obtained for each statement. Thematic analysis was 
performed on free text responses. The final ranking in 
Round 3 of the medication safety problem was weighted to 
account for the variation in stakeholder group size.
reSultS
The Delphi study was conducted from January 2015 to May 
2015. The total number of participants across the three 
groups was 166 (tables 1 and 2).
In Round 1 the majority of respondents across the three 
groups were from Riyadh (n=130, 80.7%). Fifty- two per cent 
of participants were female (n=84, n=2 missing), and the 
mean age was 35.4 (SD 11.5) years (table 3). For detailed 
demographics for each group see online supplementary 
tables 2, 3 and 4.
Consensus
The total number of items for which consensus was achieved 
in each group after completion of Rounds 1 and 2 was 53 
items in the pharmacy user group, 51 items in the profes-
sional group and 43 items in the community pharmacy 
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Figure 1 The Delphi process.
group (figure 1). Across the three stakeholder groups 
consensus was achieved with 28 items. The pharmacy users 
and professional groups agreed on 41 items (47% of these 
items were related to external factors). However, commu-
nity pharmacists achieved the lower levels of consensus 
on items related to external factors. No items under task 
factors and medication factors achieved consensus within 
the community pharmacy group. Table 4 shows items 
that reached consensus across the stakeholder groups. 
Community pharmacists achieved consensus on all factors 
related to physician and patient behaviour and had the 
highest percentage of consensus among the three groups 
for factors related to work, such as high workload and low 
salaries. However, the pharmacy users group had the largest 
number of items achieving consensus related to task factors 
and medication. Professionals attributed problems to lack 
of coordination between regulators, commercial pressure 
and lack of enforcement of regulations.
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Table 2 Participants' completion rates across three rounds
Round number
Participants completion 
rate
% (n)
R1+R2+R3 61 (102)
R1+R2 8 (13)
R1+R3 5 (9)
R2+R3 0.6 (1)
R1* 22 (37)
R2* 2 (4)
R3* 0
Total number of participants 166
*Responders who only responded to this round.
R1, Round 1; R2, Round 2.
Table 3 Demographics of participants in Round 1
Characteristic
Pharmacy users Professionals
Community 
pharmacists Total
% (n) % (n) % (n) % (n)
Number of participants R1 124 12 25 161
Gender – female 64 (79) 41.6 (5) 0 52 (84)
Age (years.) mean (SD) 35.8 (12) 37.8 (13.6) 32.4 (7.1) 35.4 (11.5)
Nationality
  Saudi 100 (124) 100 (12) 0 84.4 (136)
  Non- Saudi 0 0 100 (25) 15.5 (25)
Highest educational qualification
  High school 13 (16) 0 0 10 (16)
  Bachelor’s 59 (73) 33 (4) 92 (23) 62 (100)
  Master’s 19 (24) 42 (5) 8 (2) 19 (31)
  PhD 7 (9) 25(3) 0 7 (12)
Geographical distribution
Central region
  Riyadh 76.7 (95) 83 (10) 100 (25) 80.7 (130)
  Al Qassim 10.5 (13) – – 8.1 (13)
  Hail 1.6 (2) – – 1.2 (2)
Eastern region 4.8 (6) 8 (1) – 4.3 (7)
Western region 2.4 (3) – – 1.9 (3)
Northern region 0.8 (1) – – 0.6 (1)
Outside Saudi Arabia 2.4 (1) 8 (1) – 1.2 (2)
The community pharmacy group was the only group 
that did not achieve consensus on the general statement 
‘Medication safety problems in community pharmacies in 
Saudi Arabia are a major problem’ (online supplementary 
table 5). Medication safety problems that did not achieve 
consensus and were excluded from Round 3 are available 
(online supplementary table 6). Five medication safety 
problems reached more than 70% disagreement (ie, 1 or 
2 on the Likert scale) throughout the three rounds by the 
community pharmacy group (online supplementary table 
7) meaning community pharmacists did not consider these 
medication safety problems as problems. The professional 
group also considered one of these items not a medica-
tion safety problem: ‘poor quality of medication in Saudi 
Arabia’.
Free text comments from respondents in Round 1 
revealed no new themes. Examples of comments were the 
lack of enforcement of regulations and the lack of clear 
written Arabic information for patients.
Prioritisation of consensus items
The medication safety problems (28 items) (table 4) for 
which consensus was achieved across all groups were prior-
itised in Round 3 (figure 2). The item ranked number one 
in importance most often across the three groups was ‘Phar-
macies lacking facilities to provide different services such 
as counselling and compounding medication’; 58% of all 
participants ranked it as first. Table 5 shows the items prior-
itised based on stakeholder group and table 6 according to 
the HFF. All three groups achieved consensus on the same 
item under ‘communication and information exchange’: 
‘Patients not providing full information about their health 
condition’. The pharmacy users and the professional group 
prioritised the same items under the following HFF cate-
gories: organisational, work, task, patient behaviour and 
medication.
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Table 4 Medication safety problems which consensus was achieved across stakeholder groups after completing round 1 and 
2
Human factors Statement
External factors The lack of training programmes, for example, residency programmes, in the 
undergraduate curriculum for pharmacists.
Having multiple healthcare providers for a single patient.
Commercial pressure from pharmaceutical companies on prescribing physicians.
Organisational and management 
factors
The lack of a patient database in community pharmacies in Saudi Arabia.
The lack of drug information software resources that help pharmacists retrieve 
information quickly.
Work factors Pharmacist long working hours
Pharmacies lacking facilities to provide different services such as counselling and 
compounding medication.
Physician factors Illegible physicians’ handwriting.
Physicians prescribing unnecessary medications.
The lack of communication between the pharmacist and the prescribing physician to 
check prescriptions.
Pharmacist factors The lack of post- registration education for pharmacists.
Communication and information 
exchange
Patients not requesting information about medication.
Patients not providing full information about their health condition.
Patients not collecting their medication directly from their community pharmacy, that is, 
collected by someone else such as their driver, spouse, etc.
Patient behaviour Patients diagnosing and treating themselves independently of any healthcare 
professional.
Patients using other people’s medicine (family and friends) without approval of their 
physician.
Patients not following pharmacists’ instructions on using medication.
Patients pressuring pharmacists to supply prescription- only medication without a 
prescription.
Patients pressuring physicians to prescribe medication.
Lack of patient awareness of medication safety problems.
Medication being treated like a commodity in Saudi Arabia.
Patient factors Patients with long- term conditions.
Older patients.
Children.
Less educated patients.
Less educated caregivers, for example, family.
Patients using multiple medications.
Patients with allergies.
DISCuSSIon
In this study a wide range of medication safety problems 
achieved consensus across the three groups. Medica-
tion safety problems were prioritised differently based on 
stakeholder group (table 5) and human factor category 
(table 6). The medication safety problem that was ranked 
highest across all groups was ‘Pharmacies lacking facil-
ities to provide different services such as counselling and 
compounding medication’ (figure 2).
The top six prioritised items focused on pharmacy design, 
communication between pharmacists and physicians, 
patient databases, pharmacists’ continuing education, 
pharmacists’ working hours and unnecessary prescribing. 
These factors map to the following elements of the HFF: 
work, team, organisational and pharmacist factors. These 
have been identified as sociotechnical factors in other 
studies.2–4 Harvey et al3 explained that community pharmacy 
is a complex environment. Teams of people, processes, 
workloads, protocols, pharmacy resources, organisational 
systems, technical systems and space are involved. In order 
to understand safety problems, all factors have to be taken 
into account and the relationships between the teams of 
people and other components are important in dispensing 
safely.3
The design of the pharmacy was ranked as the number 
one priority as a medication safety problem across all groups. 
The layout of the pharmacy and lack of privacy can mean 
that it is difficult for patients to engage in conversation and 
share information with the community pharmacist, and for 
pharmacists to provide public health services and coun-
selling.32–34 Privacy violations include overhearing conver-
sations, medication being visible at the counter, calling 
out consumers’ names to collect their medication and 
mentioning medicines by name.35 Pharmacies should be 
designed to provide full privacy and facilitate counselling in 
a private, comfortable space, ensuring proper information 
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Figure 2 Top ranked medication safety problems across all stakeholder group. POM, prescription only medication.
Table 5 Top five ranked medication safety problems by stakeholder group
Rank Pharmacy users Professionals Community pharmacists
1 Pharmacies lacking facilities to 
provide different services such 
as counselling and compounding 
medication.
Pharmacies lacking facilities to 
provide different services such 
as counselling and compounding 
medication.
The lack of drug information software 
resources that help pharmacists 
retrieve information quickly.
2 Lack of community pharmacists 
adhering to regulations.
Look- alike medication or sound- alike 
medication, which are medicine brand 
names that look or sound the same 
as other medicine brand names when 
written or spoken.
Pharmacists’ long working hours.
3 The lack of communication between 
the pharmacist and the prescribing 
physician.
Patients using multiple medications. Patients not providing full information 
about their health condition.
4 The lack of a patient database in 
community pharmacies in Saudi 
Arabia.
The lack of a patient database in 
community pharmacies in Saudi 
Arabia.
The lack of a patient database in 
community pharmacies in Saudi 
Arabia.
5 The lack of post- registration 
education for pharmacists.
The lack of knowledge of community 
pharmacists.
Commercial pressure from 
pharmaceutical companies on 
prescribing physicians.
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Table 6 Prioritisation of medication safety problems according to the human factors framework across stakeholder groups
Human factors Pharmacy users Professional Community pharmacists
External factors Having more than one regulatory body 
to regulate community pharmacy in 
Saudi Arabia, for example, Ministry 
of Health and Saudi Food and Drug 
Authority.
The lack of enforcement of regulations 
by the Ministry of Health.
Commercial pressure from 
pharmaceutical companies on 
prescribing physicians.
Organisational and 
management factors
The lack of a patient database in 
community pharmacies in Saudi 
Arabia.
The lack of a patient database in 
community pharmacies in Saudi 
Arabia.
The lack of drug information software 
resources that help pharmacists 
retrieve information quickly.
Work factors Pharmacies lacking facilities to provide 
different services such as counselling 
and compounding medication.
Pharmacies lacking facilities to provide 
different services such as counselling 
and compounding medication.
Pharmacists’ long working hours.
Physician factors The lack of communication between 
the pharmacist and the prescribing 
physician to check prescriptions.
Physicians prescribing unnecessary 
medication.
Illegible physicians’ handwriting.
Pharmacist factors The lack of community pharmacists 
adhering to regulations.
The lack of knowledge of community 
pharmacists.
The lack of post- registration education 
for pharmacists.
Task factors Supplying prescription medication to 
patients without a prescription.
Supplying prescription medication to 
patients without a prescription.
The lack of proper labelling of 
medication from medications supplied 
from community pharmacies.
Communication 
and information 
exchange
Patients not providing full information 
about their health condition.
Patients not providing full information 
about their health condition.
Patients not providing full information 
about their health condition.
_ The lack of information provided by 
pharmacists in the form of counselling.
_
The lack of clear, understandable 
spoken medication information in 
Arabic provided to patients.
Patient behaviour Lack of patient awareness of 
medication safety problems.
Lack of patient awareness of 
medication safety problems.
Patients diagnosing and treating 
themselves independently of any 
healthcare professional.
Medication Look- alike medication or sound- alike 
medication, which are medicine brand 
names that look or sound the same 
as other medicine brand names when 
written or spoken.
Look- alike medication or sound- alike 
medication, which are medicine brand 
names that look or sound the same 
as other medicine brand names when 
written or spoken.
_
Patient 
characteristics
Patients with long- term conditions. Patients using multiple medications. Older patients.
exchange and the safe supply of medication. Dedicated 
locations should be available for all services provided, such 
as vaccinations and other public health services.
Poor physical pharmacy design contributes to other medi-
cation safety challenges, such as dispensing errors.4 36 Phar-
macy layout is an important factor in ensuring a reduction 
in work stress and interruptions.37 A spaciously designed 
pharmacy allows easy movement and workflow, poten-
tially contributing to a reduction in pharmacist stress and 
dispensing errors.37
An interesting finding of the current study is the seventh 
item prioritised under the patient factor ‘Patients not 
providing full information about their health condition’. A 
limited number of studies have identified the context of this 
behaviour and its impact on patient safety.21 22 One possible 
explanation is that research on medication safety problems 
in community pharmacy has tended to focus on sociotech-
nical factors with very limited data on patient behaviour.8–10 
Further inquiry is needed to understand the reasons for 
such behaviour from the viewpoints of pharmacy users, 
through understanding their attitudes and perceptions 
towards sharing information with pharmacy personnel.
The community pharmacist group considered five items 
not to be medication safety problems; ‘Generic substitu-
tion’ was one of the five items, in contrast to the pharmacy 
users’ group and professional who categorised it as a medi-
cation safety.
Patient insecurity due to generic substitution was reported 
as one of the major causes of drug- related problems 
related to medication supplied by community pharmacies 
in Germany.38 Further research is needed to understand 
the attitudes and concerns of pharmacy users to generic 
medication. Possible reasons identified in an earlier study 
include worries about medication quality and the phar-
macist’s knowledge.1 In addition, research is needed to 
understand community pharmacists attitudes regarding 
supplying and counselling generic medication.
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Study implications
A number of measures have been taken in Saudi Arabia to 
ensure the safe supply and use of medication from commu-
nity pharmacies, such as enforcement of regulations and 
establishing a national electronic patient database,7 8 but 
further areas for improvements are needed. This study 
prioritisation exercise could be used as a ‘road map’ for 
designing a systematic approach to improving medication 
safety in community pharmacy in Saudi Arabia. The find-
ings could aid organisations responsible for the regulation 
of community pharmacy to target key problems and set 
future research priorities based on stakeholder perspective 
and human factors categories.
The study supports the use of HFF to understand the 
medication safety problems in community pharmacy. It 
would be useful to explore the use of HFF in community 
pharmacy outside the Saudi context.
Strengths and limitations of this study
The main strength of this study is that it involved represen-
tatives of various stakeholders of community pharmacy in 
defining medication safety problems, achieving consensus 
and prioritisation of these factors. This has provided 
comprehensiveness of the medication safety problems 
evident by no further medication safety problems being 
identified in the open- ended question asked in Round 1.
The HFF facilitated the categorisation and under-
standing of the medication safety problems. In addition, 
it provided theoretical underpinning to this study.39 
The use of theory helps to guide research adds context 
and provides in- depth description, interpretation and 
explanation.39
Using the option of an online questionnaire helped to 
minimise missing data and facilitate the speed in adminis-
trating the questionnaires through the three rounds. The 
attrition rate in later rounds, which is often a problem in 
Delphi studies, was very not substantial.40
However, there are a number of limitations with this 
study. First, the use of online questionnaires restricts partic-
ipation to those who have internet access and computer 
skills. Second, we used social media to recruit pharmacy 
users. Saudi Arabia is the country with the highest number 
of active Twitter users in the Arab region (2.4 million 
users), accounting for more than 40% of the region’s active 
Twitter users.41 This helped to recruit pharmacy users 
from different geographical areas in Saudi Arabia, which 
might increase the chances of generalisability of the results. 
The snowballing technique and the use of WhatsApp also 
helped to reach a wider population. Nevertheless, using 
social media may introduce selection bias
Third, the majority of responders were from Riyadh 
city, the capital of Saudi Arabia, where 25% of the Saudi 
population live. 42 Although Riyadh residents come from 
different parts of Saudi Arabia, their views might not be 
representative of people across Saudi Arabia.
Fourth, the pharmacy user group participants were young 
adults with Bachelor degrees and their responses may differ 
from less educated or elderly individuals. However, it worth 
noting that 65% of the Saudi population is under the age of 
40 years and 23% have college degrees.42
Fifth, a high percentage of pharmacy users chose ‘I do 
not know’ during Rounds 1 and 2 possibly as several state-
ments in these two rounds were related to community 
pharmacy regulations.
Finally, unequal proportion of participants through the 
three rounds in each stakeholder group. Pharmacy users 
were over- represented (n=124) while only 12 ‘professionals’ 
participated. Different sampling techniques was used for 
each group. We used convenient sampling to recruit 37 
professional and only 12 responded. Low participation rates 
may have been due to time constraints and work pressures.
As for the pharmacy user group, previous experi-
ence with flyers and notices in community centres and 
community pharmacies showed low response rate so we 
used social media to recruit.1 There was a high number of 
respondents exceeding our expectations of only 25 and 
we decided not to exclude.
Stakeholder responses were treated equally through 
all three rounds, but the final ranking of the medication 
safety problem was weighted to account for the variation 
in stakeholder group size.
ConCluSIon
This study identified the medication safety priorities 
affecting current community pharmacy practice among 
three stakeholder groups in Saudi Arabia. The lack of facil-
ities to provide different services, such as counselling, was 
the most important problem agreed by all three groups, 
followed by the failure of communication between physi-
cians and community pharmacists, and the lack of a patient 
database in community pharmacy. Each stakeholder group 
had different perspectives on medication safety, demon-
strating the importance of exploring and including different 
stakeholder perspectives on topics of such importance.
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